News

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...
Former Playboy star Kendra Wilkinson revealed that she started taking a weight-loss drug but threw the medication away after ...
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...
The positive data gives Eli Lilly the green light to file the drug with the FDA by the end of the year for a weight-loss ...
The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...
The announcement adds to a string of setbacks in Pfizer’s bid to win a slice of the booming market that Wall Street projects ...
Lilly, which makes weight loss injections, unveils trial result showing Type 2 diabetes sufferers lost 8% of body weight ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, Wegovy, Mounjaro and Zepbound, a clinical trial shows.
The first weight loss pill to suppress appetite has been shown to work in clinical trials, offering a ray of hope to the 40% ...
Danish pharmaceutical company Novo Nordisk is set to launch its anti-diabetes and weight-loss drug Wegovy in India, aiming to ...
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...